difference between tirzepatide and semaglutide for weight loss vs Tirzepatide: Key Differences Semaglutide vs. Tirzepatide: Which GLP-1

doi: 10.1177/2042018820934955 7

Microglia-specific overexpression of -synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity

Evidence suggests that GLP-1 receptor agonists can effectively reduce visceral adipose tissue, though the degree to which this reduction is preferential compared to subcutaneous fat continues to be investigated

The FDA classifies semaglutide as Category C for pregnancy, meaning human studies are lacking and animal studies have shown mixed results

Wegovy follows with 9.6-15% weight loss, while Ozempic users typically experience 10-15% reduction